Evaluation of Circulating Tumor DNA in Patients with Ovarian Cancer Harboring Somatic PIK3CA or KRAS Mutations

PURPOSE: Circulating tumor DNA (ctDNA) is an attractive source for liquid biopsy to understand molecular phenotypes of a tumor non-invasively, which is also expected to be both a diagnostic and prognostic marker. PIK3CA and KRAS are among the most frequently mutated genes in epithelial ovarian cance...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancer Res Treat
Päätekijät: Ogasawara, Aiko, Hihara, Taro, Shintani, Daisuke, Yabuno, Akira, Ikeda, Yuji, Tai, Kenji, Fujiwara, Keiichi, Watanabe, Keisuke, Hasegawa, Kosei
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Korean Cancer Association 2020
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7577815/
https://ncbi.nlm.nih.gov/pubmed/32599986
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2019.688
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia